Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine: An Open-Label Randomized Trial.

NCT03885154 is registered in ClinicalTrials.gov with Kimberly S Jones as lead sponsor.

NCT NCT03885154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03885154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine: An Open-Label Randomized Trial.
Lead sponsor
Kimberly S Jones
Phase
Phase 2
Overall status
Terminated
Start date
October 3, 2017
Completion date
March 19, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine in children